<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mobihealthnews&#187; psychiatric</title>
	<atom:link href="http://mobihealthnews.com/tag/psychiatric/feed/" rel="self" type="application/rss+xml" />
	<link>http://mobihealthnews.com</link>
	<description>mobihealthnews - the daily mHealth industry monitor.  Subscribe for our free weekly e-newsletter!</description>
	<lastBuildDate>Thu, 24 May 2012 12:07:24 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Novartis invests $24M in Proteus Biomedical</title>
		<link>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/</link>
		<comments>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/#comments</comments>
		<pubDate>Tue, 12 Jan 2010 13:47:42 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[Diovan]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[organ transplantation]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[psychiatric]]></category>
		<category><![CDATA[tuberculosis]]></category>
		<category><![CDATA[venture capital]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=6013</guid>
		<description><![CDATA[Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical&#8217;s sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/feed/</wfw:commentRss>
		<slash:comments>8</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 1.751 seconds -->

